PlainRecalls
FDA Drug Low Class III Ongoing

Atropine Sulfate Ophthalmic Solution, USP 1%, For Topical Application To The Eye, 2 mL bottle, Sterile, Rx only, Distributed by: Akorn Operating Company LLC, Gurnee, IL 60031. NDC: 17478-215-02

Reported: February 15, 2023 Initiated: January 30, 2023 #D-0265-2023

Product Description

Atropine Sulfate Ophthalmic Solution, USP 1%, For Topical Application To The Eye, 2 mL bottle, Sterile, Rx only, Distributed by: Akorn Operating Company LLC, Gurnee, IL 60031. NDC: 17478-215-02

Reason for Recall

Failed Stability Specifications: Out of specification test results for viscosity was identified at the 12M stability timepoint.

Details

Recalling Firm
Akorn, Inc.
Units Affected
45,117 Bottles
Distribution
Nationwide in the USA and Puerto Rico
Location
Gurnee, IL

Frequently Asked Questions

What product was recalled?
Atropine Sulfate Ophthalmic Solution, USP 1%, For Topical Application To The Eye, 2 mL bottle, Sterile, Rx only, Distributed by: Akorn Operating Company LLC, Gurnee, IL 60031. NDC: 17478-215-02. Recalled by Akorn, Inc.. Units affected: 45,117 Bottles.
Why was this product recalled?
Failed Stability Specifications: Out of specification test results for viscosity was identified at the 12M stability timepoint.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 15, 2023. Severity: Low. Recall number: D-0265-2023.